Media Summary: Rami Komrokji, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses the new World Health ... Presented by Dr. Yee, MD, this webinar offers invaluable information on Panelists Vinod Pullarkat, MD; Jamile Shammo, MD; Rami S. Komrokji, MD; and Thomas Prebet, MD, PhD, discuss heterogeneity ...

Updates On Mds Classifications - Detailed Analysis & Overview

Rami Komrokji, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses the new World Health ... Presented by Dr. Yee, MD, this webinar offers invaluable information on Panelists Vinod Pullarkat, MD; Jamile Shammo, MD; Rami S. Komrokji, MD; and Thomas Prebet, MD, PhD, discuss heterogeneity ... In this discussion, Uma Borate, MD, The Ohio State University, Columbus, OH, Luca Lanino, MD, PhD, Yale University, New ... Norbert Vey, MD, PhD, Paoli-Calmettes Institute, Marseille, France, shares some of his highlights from the Dr. Kamran Mirza, MD, PhD, Clinical Professor of Pathology, University of Michigan, USA, discusses "

What are myelodysplastic syndromes? Myelodysplastic syndromes, or James M. Foran, MD, FRCP, and Azra Raza, MD, explain how Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the key features ... A roundtable discussion, moderated by Amer Zeidan, MBBS, MHS, of Yale University, focused on the latest Dive deep into the latest "Advances in Molecular Eric Solary, MD, Gustave Roussy Institute, Paris, France, discusses the debate surrounding the two recently released ...

... International Bone Marrow Failure Scientific Symposium Featured Speakers: Mina Xu, MD - Yale University Dr Aditi Shastri from Montefiore Medical Center comments on Michael Rauh, PhD, MD, FRCPC, Queen's University School of Medicine, Kingston, Canada, outlines the various molecular and ... In this video, Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an ...

Photo Gallery

Updates on MDS Classifications
Prognostic value of the updated ICC and WHO classifications for MDS
MDS Classifications Webinar 2025
Understanding the Recent WHO MDS Classification Updates
Advances made in MDS classification and risk stratification: ongoing work & future perspectives
MDS 2023 highlights: classification and risk stratification systems & progression from CH to MDS
#HEMEPATH MDS Morphology and Beyond: Pathology Updates for the Modern Practitioner
Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology
Classification and Prognosis in MDS
Automated tool for MDS classification using the WHO & ICC classification systems
How Is MDS Classification, Prognosis Changing?
Advances in AML & MDS Classification and MRD Surveillance - TUMS Grand Round
Sponsored
Sponsored
View Detailed Profile
Updates on MDS Classifications

Updates on MDS Classifications

Did you know that not every

Prognostic value of the updated ICC and WHO classifications for MDS

Prognostic value of the updated ICC and WHO classifications for MDS

Rami Komrokji, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, discusses the new World Health ...

Sponsored
MDS Classifications Webinar 2025

MDS Classifications Webinar 2025

Presented by Dr. Yee, MD, this webinar offers invaluable information on

Understanding the Recent WHO MDS Classification Updates

Understanding the Recent WHO MDS Classification Updates

Panelists Vinod Pullarkat, MD; Jamile Shammo, MD; Rami S. Komrokji, MD; and Thomas Prebet, MD, PhD, discuss heterogeneity ...

Advances made in MDS classification and risk stratification: ongoing work & future perspectives

Advances made in MDS classification and risk stratification: ongoing work & future perspectives

In this discussion, Uma Borate, MD, The Ohio State University, Columbus, OH, Luca Lanino, MD, PhD, Yale University, New ...

Sponsored
MDS 2023 highlights: classification and risk stratification systems & progression from CH to MDS

MDS 2023 highlights: classification and risk stratification systems & progression from CH to MDS

Norbert Vey, MD, PhD, Paoli-Calmettes Institute, Marseille, France, shares some of his highlights from the

#HEMEPATH MDS Morphology and Beyond: Pathology Updates for the Modern Practitioner

#HEMEPATH MDS Morphology and Beyond: Pathology Updates for the Modern Practitioner

Dr. Kamran Mirza, MD, PhD, Clinical Professor of Pathology, University of Michigan, USA, discusses "

Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology

Myelodysplastic syndromes - causes, symptoms, diagnosis, treatment, pathology

What are myelodysplastic syndromes? Myelodysplastic syndromes, or

Classification and Prognosis in MDS

Classification and Prognosis in MDS

James M. Foran, MD, FRCP, and Azra Raza, MD, explain how

Automated tool for MDS classification using the WHO & ICC classification systems

Automated tool for MDS classification using the WHO & ICC classification systems

Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, highlights the key features ...

How Is MDS Classification, Prognosis Changing?

How Is MDS Classification, Prognosis Changing?

A roundtable discussion, moderated by Amer Zeidan, MBBS, MHS, of Yale University, focused on the latest

Advances in AML & MDS Classification and MRD Surveillance - TUMS Grand Round

Advances in AML & MDS Classification and MRD Surveillance - TUMS Grand Round

Dive deep into the latest "Advances in Molecular

Similarities between the WHO and ICC classifications for MDS & the need to create a unified approach

Similarities between the WHO and ICC classifications for MDS & the need to create a unified approach

Eric Solary, MD, Gustave Roussy Institute, Paris, France, discusses the debate surrounding the two recently released ...

MDS CLASSIFICATION & PROGNOSIS

MDS CLASSIFICATION & PROGNOSIS

... International Bone Marrow Failure Scientific Symposium Featured Speakers: Mina Xu, MD - Yale University

How is MDS classified?

How is MDS classified?

To learn more visit http://www.YouAndMDS.com

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

Higher-risk MDS and AML: How new guidelines are changing diagnosis, classification and management

The 2022

Updates in the Myelodysplastic Syndromes: 2023 Best of Hematology

Updates in the Myelodysplastic Syndromes: 2023 Best of Hematology

Dr Aditi Shastri from Montefiore Medical Center comments on

The molecular and clinical classifications of MDS

The molecular and clinical classifications of MDS

Michael Rauh, PhD, MD, FRCPC, Queen's University School of Medicine, Kingston, Canada, outlines the various molecular and ...

ASCP | MLS | MLT | Myelodysplastic Syndromes | MDS

ASCP | MLS | MLT | Myelodysplastic Syndromes | MDS

We'll unravel the complexity of

A practical approach to the classification of MDS

A practical approach to the classification of MDS

In this video, Rashmi Kanagal-Shamanna, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an ...